OTC/bb Monday morning. Name
Post# of 63704
Posted On: 04/01/2013 7:18:15 AM
OTC/bb Monday morning.
| Name | Symbol | Last Price | Chg | % Chg | Open | High | Low | Volume |
|---|
| Journal of Radiology Inc. Common | JRRD | 0.0005 |  | 0.0001 | 25.00% | 0.0004 | 0.0005 | 0.0002 | 0.00 |
| Federal National Mortgage Association | FNMA | 0.685 | | 0.0844 | 14.05% | 0.5709 | 0.75 | 0.511 | 0.00 |
| A.P. Pharma Inc. | APPA | 0.37 |  | -0.21 | -36.21% | 0.2802 | 0.4075 | 0.28 | 0.00 |
| Attitude Drinks Inc NEW | ATTD | 0.0002 |  | 0.00 | 0.00% | 0.0002 | 0.0002 | 0.0001 | 0.00 |
| Real Estate Contacts Inc. | REAC | 0.0019 | | -0.0002 | -9.52% | 0.0022 | 0.0022 | 0.0015 | 0.00 |
| Federal Home Loan Mortgage Corporation | FMCC | 0.6771 | | 0.086 | 14.55% | 0.555 | 0.729 | 0.5101 | 0.00 |
| Goff Corp | GOFF | 0.4535 | | 0.025 | 5.83% | 0.435 | 0.459 | 0.41 | 0.00 |
| Innovative Product Opportunities Inc | IPRU | 0.0032 | | 0.0007 | 28.00% | 0.0025 | 0.01 | 0.0025 | 0.00 |
| Active Health Foods Inc. Common | AHFD | 0.0006 | | -0.0001 | -14.29% | 0.0007 | 0.0007 | 0.0006 | 0.00 |
| Cord Blood America Inc. | CBAI | 0.004 | | -0.0003 | -6.98% | 0.0045 | 0.0045 | 0.0039 | 0.00 |
| 04/01/13 7:00 AM EDT | Cellceutix Selected for Poster Presentation on Kevetrin at 2013 ASCO Meeting - Marketwire |
| 04/01/13 7:00 AM EDT | ProtoKinetix Sells Exclusive Rights to One of the Numerous AAGP(TM) Applications - Business Wire |
| 04/01/13 6:31 AM EDT | Webxu Announces Successful Launch of New Auto Vertical with Consumer Site - PR Newswire |
| 04/01/13 6:30 AM EDT | Mexus Gold US Update - Globe Newswire |
| 04/01/13 5:00 AM EDT | NTRR Considers Healthier Technologies for $1.7 Billion Medical Marijuana Market - Business Wire |
| 04/01/13 5:00 AM EDT | OBJE Selects Winner in Stupid Pixels Music Challenge - Business Wire |
| 03/31/13 10:05 PM EDT | Sorrento Therapeutics, Inc. and IGDRASOL Announce Three Presentations on Cynviloq(TM) (IG-001; paclitaxel polymeric micelle) at the American Association of Cancer Research (AACR) Meeting - PR Newswire |
(0)
(0)Scroll down for more posts ▼